|3.15|| -0.16 / -4.83%|
Array BioPharma Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Its proprietary drug development pipeline focuses on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. It also collaborates with pharmaceutical and biotechnology companies under which the firm has out-licensed certain proprietary drug programs for further research, development, and commercialization. The company was founded by Kevin Koch, Anthony Piscopio, K.C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO.
|Ron Squarer||Chief Executive Officer & Director|
|Andrew R. Robbins||Chief Operating Officer|
|David J. Horin||Chief Financial Officer|
|Nick A. Saccomano||Chief Scientific Officer|
|Victor Sandor||Chief Medical Officer|